Aristo Pharmaceuticals Pvt Ltd
Next 500 2015
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#94(2015)
#94(2015)
Financial Data 2024
Revenue
5,184
(INR Cr)
Net Operating Income
4,750
(INR Cr)
Assets
6,206
(INR Cr)
Profit
1,466
(INR Cr)
Net Worth
6,040
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 5184 13.6% | 4563 5.5% | 4323 35.2% | 3197 1.5% | 3150 11.2% | 2832 13.7% | 2490 9.0% | 2286 8.2% | 2112 21.3% | 1741 12.1% | 1553 21.4% | 1280 12.3% | 1140 7.2% | 1063 9.4% | 971 17.1% | 829 - |
| Net Operating Income (INR Cr) | 4750 8.81% | 4365 6.51% | 4099 35.86% | 3017 -0.29% | 3025 16.37% | 2600 11.13% | 2340 8.38% | 2159 7.97% | 1999 22.43% | 1633 15.00% | 1420 10.96% | 1280 12.30% | 1140 7.21% | 1063 17.76% | 903 16.77% | 773 14.95% |
| Profit (INR Cr) | 1466 16.9% | 1254 0.8% | 1244 38.1% | 901 24.2% | 726 18.4% | 613 1.7% | 603 13.0% | 533 19.2% | 447 9.3% | 409 26.7% | 323 10.2% | 293 8.6% | 270 4.4% | 258 23.9% | 208 37.3% | 152 - |
| Assets (INR Cr) | 6206 18.5% | 5236 19.4% | 4384 22.3% | 3586 17.1% | 3062 27.7% | 2399 0.9% | 2378 21.2% | 1961 22.1% | 1606 8.6% | 1480 2.0% | 1450 8.4% | 1338 17.3% | 1141 14.4% | 998 14.5% | 871 12.9% | 772 - |
| Net Worth (INR Cr) | 6040 19.1% | 5070 19.0% | 4260 23.1% | 3461 18.3% | 2927 32.8% | 2203 -4.8% | 2315 26.1% | 1835 24.7% | 1472 4.2% | 1413 6.8% | 1323 8.9% | 1216 9.9% | 1106 15.6% | 957 16.7% | 820 11.9% | 733 6.8% |
| Employee Cost (INR Cr) | 681 6.2% | 641 9.8% | 584 25.8% | 464 6.3% | 437 12.1% | 390 19.2% | 327 16.0% | 282 22.5% | 230 14.6% | 201 17.0% | 172 - | 0 - | 0 - | 0 - | 0 - | 0 - |
| Interest Cost (INR Cr) | 11 | 9 | 7 | 8 | 9 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Cash & Bank Balance (INR Cr) | 3008 | 677 | 1774 | 848 | 314 | 1143 | 462 | 330 | 188 | 152 | 65 | 230 | 159 | 681 | 747 | 657 |
| Total Debt (INR Cr) | 0 | 0 | 0 | 0 | 0 | 165 | 58 | 121 | 130 | 64 | 124 | 123 | 35 | 40 | 51 | 39 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 28.3% | 27.5% | 28.8% | 28.2% | 23.0% | 21.7% | 24.2% | 23.3% | 21.2% | 23.5% | 20.8% | 22.9% | 23.7% | 24.3% | 21.5% | 18.3% |
| Profit As % Of Assets | 23.6% | 24.0% | 28.4% | 25.1% | 23.7% | 25.6% | 25.4% | 27.2% | 27.8% | 27.7% | 22.3% | 21.9% | 23.6% | 25.9% | 23.9% | 19.7% |
| Profit As % Of Networth | 24.3% | 24.7% | 29.2% | 26.0% | 24.8% | 27.8% | 26.0% | 29.1% | 30.4% | 29.0% | 24.4% | 24.1% | 24.4% | 27.0% | 25.4% | 20.7% |
| Interest Cost to EBITDA % | 0.7% | 0.6% | 0.5% | 0.8% | 1.0% | 0.1% | 0.1% | 0.2% | 0.2% | 0.3% | 0.5% | - | - | - | - | - |
| Debt to Equity Ratio | - | - | - | - | - | 0.07 | 0.03 | 0.07 | 0.09 | 0.04 | 0.09 | 0.10 | 0.03 | 0.04 | 0.06 | 0.05 |
| RONW | 26.4% | 26.9% | 32.2% | 28.2% | 28.3% | 27.1% | 29.1% | 32.3% | 31.0% | 29.9% | 25.4% | 25.2% | 26.1% | 29.1% | 26.8% | 21.4% |
| ROCE | 33.8% | 33.6% | 39.2% | 35.0% | 35.0% | 33.2% | 38.4% | 42.7% | 41.6% | 35.5% | 29.5% | 30.7% | 34.2% | 39.7% | 38.6% | 31.8% |